The biological fate of sodium prasterone sulfate after vaginal administration. I. Absorption and excretion in rats. 1992

M Sakaguchi, and T Sakai, and Y Adachi, and T Kawashima, and N Awata
Product R & D Laboratories, Pharmaceuticals Research Center, Kanebo, Ltd., Osaka, Japan.

The absorption and excretion of sodium prasterone sulfate (PS) (sodium dehydroepiandrosterone sulfate) were studied in rats after vaginal administration of 14C-PS. In late pregnant rats, maximum plasma level (Cmax) appeared at 2-4 h after dosing and both Cmax and the area under the plasma concentration-time curve (AUC) increased proportionally with increased dose up to 4.0 mg/kg. The radioactivity administered was almost completely recovered from urine and feces during a 72 h postdosing period. The percentages of radioactivity excreted in urine and feces were 58% and 40% of the dose, respectively. The biliary excretion was 46% of the dose within 48 h and about half of the radioactive biliary excreta entered the enterohepatic circulation system. The vaginal absorption of PS was markedly affected by the estrous cycle stage and the progress of pregnancy. The vaginal absorption of PS was predominant at metestrus and diestrus and during late pregnancy.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004971 Estrus The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000282 Administration, Intravaginal The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories. Administration, Vaginal,Drug Administration, Vaginal,Instillation, Vaginal,Intravaginal Administration,Vaginal Drug Administration,Vaginal Administration,Administration, Vaginal Drug,Administrations, Intravaginal,Administrations, Vaginal,Administrations, Vaginal Drug,Drug Administrations, Vaginal,Instillations, Vaginal,Intravaginal Administrations,Vaginal Administrations,Vaginal Drug Administrations,Vaginal Instillation,Vaginal Instillations

Related Publications

M Sakaguchi, and T Sakai, and Y Adachi, and T Kawashima, and N Awata
September 1979, Biochimica et biophysica acta,
M Sakaguchi, and T Sakai, and Y Adachi, and T Kawashima, and N Awata
January 1981, Journal of parenteral science and technology : a publication of the Parenteral Drug Association,
M Sakaguchi, and T Sakai, and Y Adachi, and T Kawashima, and N Awata
January 1987, The Japanese journal of antibiotics,
M Sakaguchi, and T Sakai, and Y Adachi, and T Kawashima, and N Awata
April 1995, Zhonghua fu chan ke za zhi,
M Sakaguchi, and T Sakai, and Y Adachi, and T Kawashima, and N Awata
September 1956, Acta physiologica Scandinavica,
M Sakaguchi, and T Sakai, and Y Adachi, and T Kawashima, and N Awata
October 1989, Acta medica Okayama,
M Sakaguchi, and T Sakai, and Y Adachi, and T Kawashima, and N Awata
January 1987, The Japanese journal of antibiotics,
M Sakaguchi, and T Sakai, and Y Adachi, and T Kawashima, and N Awata
January 1971, Journal of biochemistry,
M Sakaguchi, and T Sakai, and Y Adachi, and T Kawashima, and N Awata
January 1995, Acta radiologica. Supplementum,
Copied contents to your clipboard!